FDA Recalls Apollo Care Norepinephrine Injections Due to Sterility Assurance Failure
Apollo Care, LLC is recalling 1,617 bags of Norepinephrine 8 mg intravenous injection distributed in Missouri due to lack of assurance that the product meets sterility requirements.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (injectable medication) where sterility is a critical safety requirement. The FDA classified it as Class II. No illnesses or injuries are reported in the source text; therefore, per the rubric, the score does not exceed 3.
Plain-English summary
Apollo Care, LLC is recalling 1,617 bags of Norepinephrine 8 mg added to 250 mL 0.9% Sodium Chloride Injection (NDC 71170-550-25) distributed in Missouri only.
The recall was issued because the manufacturer cannot assure that the product meets sterility requirements. Norepinephrine is a critical injectable medication administered in clinical settings; sterility is a required safety standard for all intravenous products.
The affected lots are AC-016631 (expiration date 05/29/2023) and AC-016655 (expiration date 08/07/2023). Healthcare facilities and providers in Missouri who received this product should verify their inventory against these lot numbers and contact Apollo Care, LLC for instructions on handling or replacement of affected stock.
The recalled product
- Product
- Norepinephrine 8 mg added to 250 mL 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-550-25
- Manufacturer
- Apollo Care, LLC
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 1,617
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: AC-016631
- Exp. Date 05/29/2023
- AC-016655
- Exp. Date 08/07/2023
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 16 recalled by Apollo Care, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Apollo Care, LLC
See all →- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
- SevereApollo Care Recalls Semaglutide Vials Due to Particulate Matter
FDA (Drugs) · 2026-08-19
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22